- Home
- CRVS vs WOW Comparison
CRVS vs WOW Comparison
Compare CRVS & WOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- WOW
- Stock Information
- Founded
- CRVS 2014
- WOW 2001
- Country
- CRVS United States
- WOW United States
- Employees
- CRVS N/A
- WOW N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- WOW Cable & Other Pay Television Services
- Sector
- CRVS Health Care
- WOW Telecommunications
- Exchange
- CRVS Nasdaq
- WOW Nasdaq
- Market Cap
- CRVS 335.1M
- WOW 356.9M
- IPO Year
- CRVS 2016
- WOW 2017
- Fundamental
- Price
- CRVS $4.19
- WOW $4.80
- Analyst Decision
- CRVS Strong Buy
- WOW Buy
- Analyst Count
- CRVS 5
- WOW 2
- Target Price
- CRVS $12.38
- WOW $7.50
- AVG Volume (30 Days)
- CRVS 419.4K
- WOW 269.8K
- Earning Date
- CRVS 03-18-2025
- WOW 03-12-2025
- Dividend Yield
- CRVS N/A
- WOW N/A
- EPS Growth
- CRVS N/A
- WOW N/A
- EPS
- CRVS N/A
- WOW N/A
- Revenue
- CRVS N/A
- WOW $647,100,000.00
- Revenue This Year
- CRVS N/A
- WOW N/A
- Revenue Next Year
- CRVS N/A
- WOW N/A
- P/E Ratio
- CRVS N/A
- WOW N/A
- Revenue Growth
- CRVS N/A
- WOW N/A
- 52 Week Low
- CRVS $1.30
- WOW $2.31
- 52 Week High
- CRVS $10.00
- WOW $5.80
- Technical
- Relative Strength Index (RSI)
- CRVS 28.71
- WOW 59.73
- Support Level
- CRVS $4.60
- WOW $4.33
- Resistance Level
- CRVS $5.19
- WOW $5.00
- Average True Range (ATR)
- CRVS 0.30
- WOW 0.18
- MACD
- CRVS -0.06
- WOW 0.08
- Stochastic Oscillator
- CRVS 2.01
- WOW 75.88
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.